Jian-Guo Geng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jian-Guo Geng has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Jin-Tao Wang
4 shared publicationsMing Chen
Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, The Graduate School of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China
3 shared publicationsXuesong Yang
Jinan Univ, Dept Histol & Embryol, Key Lab Regenerat Med, Minist Educ,Med Coll, Guangzhou 510632, Peoples R China
3 shared publicationsCui-Ling Qi
Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangdong Key Lab Pharmaceut Bioact Subst, Guangzhou 510006, Peoples R China
2 shared publicationsJiang-Chao Li
Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangdong Key Lab Pharmaceut Bioact Subst, Guangzhou 510006, Peoples R China
2 shared publicationsLi-Jing Wang
Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, China;
2 shared publications
Latest Publications
- Open Access
- 1 January 2020
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 16 (13) , 2379-2381
Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma: Erratum
[This corrects the article DOI: 10.7150/ijbs.7723.].
- 1 January 2020
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 16 (13) , 2379-2381
Open AccessAndrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma: Erratum
[This corrects the article DOI: 10.7150/ijbs.7723.].
- RetractedOpen Access
- 1 January 2014
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 10 (4) , 404-414
Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
Insulinomas are rare tumors, and approximately 10% of insulinomas are malignant. Accumulating evidence has implicated that we still lack effective therapy to treat the patients who are diagnosed with rare malignant insulinoma. Previous studies have reported that Andrographolide (Andro) could inhibit cell cycle progression, reduce cell invasion and induce cell apoptosis in many common cancer cells. However, the effects of andro are cell type-dependent. So we emplored the β-TC-6 cells and the RIP1-Tag2 transgenic mouse model of endogenously growing insulinoma model to elucidate the possible anti-cancer effect of Andro on insulinoma, an uncommon type of malignant cancers in this study. Our experiments revealed that Andro significantly inhibited tumor growth at both the early-stage and the advanced-stage of insulinoma through targeting the TLR4/NF-κB signaling pathway. This work initially provides the evidence that the TLR4/NF-κB signaling pathway might be vital as a potential therapeutic target, and also indispensable in Andro-mediated anti-cancer effect in insulinoma.
- 1 January 2014
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 10 (4) , 404-414
RetractedOpen AccessAndrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
Insulinomas are rare tumors, and approximately 10% of insulinomas are malignant. Accumulating evidence has implicated that we still lack effective therapy to treat the patients who are diagnosed with rare malignant insulinoma. Previous studies have reported that Andrographolide (Andro) could inhibit cell cycle progression, reduce cell invasion and induce cell apoptosis in many common cancer cells. However, the effects of andro are cell type-dependent. So we emplored the β-TC-6 cells and the RIP1-Tag2 transgenic mouse model of endogenously growing insulinoma model to elucidate the possible anti-cancer effect of Andro on insulinoma, an uncommon type of malignant cancers in this study. Our experiments revealed that Andro significantly inhibited tumor growth at both the early-stage and the advanced-stage of insulinoma through targeting the TLR4/NF-κB signaling pathway. This work initially provides the evidence that the TLR4/NF-κB signaling pathway might be vital as a potential therapeutic target, and also indispensable in Andro-mediated anti-cancer effect in insulinoma.
- Open Access
- 4 February 2013
- Published by Wiley in The Anatomical Record
- Vol. 296 (3) , 533-543
Retention of Stem Cell Plasticity in Avian Primitive Streak Cells and the Effects of Local Microenvironment
Primitive streak (PS) is the first structure occurring in embryonic gastrulation, in which the epiblast cells undergo the epithelial‐mesenchymal transition to become the loose mesoderm cells subsequently. Because the mesoderm cells departing from different portions of PS are blessed with disparate migration trajectory and differentiation fate, one question is when the cell fate is determinated. To understand whether the cell fate and cell migration pattern will be alternated along with the microenvironment transformation, the traditional transplantation technology was used to replace the anterior PS cells in HH4 host embryo using posterior PS tissue labeled by green fluorescent protein (GFP) in the same stage donor embryo, and then, we tracked the migration trajectory of the GFP‐positive cells with fluorescence stereomicroscope after incubation, and eventually verified the cell contribution from the transplants with in situ hybridization and immunocytochemistry. The same experimental strategy applied for posterior PS site replacement in host embryo. We found that the transplanted posterior PS cells to anterior part of streak followed the anterior PS cell migration pattern rather than kept its posterior streak cell migration trajectory, and so did vice versa. In addition, the transplants were involved in the contribution to the subsequent organogenesis as the local PS tissues affirmed by specific expression of myocardial or hematopoietic markers. Therefore, our data strongly suggest that the PS cells still keep stem cell plasticity during gastrulation and the eventual cell fate will depend on the spatial gene expression within local microenvironment along with development. Anat Rec, 296:533–543, 2012.
- 4 February 2013
- Published by Wiley in The Anatomical Record
- Vol. 296 (3) , 533-543
Open AccessRetention of Stem Cell Plasticity in Avian Primitive Streak Cells and the Effects of Local Microenvironment
Primitive streak (PS) is the first structure occurring in embryonic gastrulation, in which the epiblast cells undergo the epithelial‐mesenchymal transition to become the loose mesoderm cells subsequently. Because the mesoderm cells departing from different portions of PS are blessed with disparate migration trajectory and differentiation fate, one question is when the cell fate is determinated. To understand whether the cell fate and cell migration pattern will be alternated along with the microenvironment transformation, the traditional transplantation technology was used to replace the anterior PS cells in HH4 host embryo using posterior PS tissue labeled by green fluorescent protein (GFP) in the same stage donor embryo, and then, we tracked the migration trajectory of the GFP‐positive cells with fluorescence stereomicroscope after incubation, and eventually verified the cell contribution from the transplants with in situ hybridization and immunocytochemistry. The same experimental strategy applied for posterior PS site replacement in host embryo. We found that the transplanted posterior PS cells to anterior part of streak followed the anterior PS cell migration pattern rather than kept its posterior streak cell migration trajectory, and so did vice versa. In addition, the transplants were involved in the contribution to the subsequent organogenesis as the local PS tissues affirmed by specific expression of myocardial or hematopoietic markers. Therefore, our data strongly suggest that the PS cells still keep stem cell plasticity during gastrulation and the eventual cell fate will depend on the spatial gene expression within local microenvironment along with development. Anat Rec, 296:533–543, 2012.
- 1 February 2011
- Published by Springer Nature in Cell Research
- Vol. 21 (4) , 609-626
Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis
The Slit family of guidance cues binds to Roundabout (Robo) receptors and modulates cell migration. We report here that ectopic expression of Slit2 and Robo1 or recombinant Slit2 treatment of Robo1-expressing colorectal epithelial carcinoma cells recruited an ubiquitin ligase Hakai for E-cadherin (E-cad) ubiquitination and lysosomal degradation, epithelial-mesenchymal transition (EMT), and tumor growth and liver metastasis, which were rescued by knockdown of Hakai. In contrast, knockdown of endogenous Robo1 or specific blockade of Slit2 binding to Robo1 prevented E-cad degradation and reversed EMT, resulting in diminished tumor growth and liver metastasis. Ectopic expression of Robo1 also triggered a malignant transformation in Slit2-positive human embryonic kidney 293 cells. Importantly, the expression of Slit2 and Robo1 was significantly associated with an increased metastatic risk and poorer overall survival in colorectal carcinoma patients. We conclude that engagement of Robo1 by Slit2 induces malignant transformation through Hakai-mediated E-cad ubiquitination and lysosomal degradation during colorectal epithelial cell carcinogenesis.
- 1 February 2011
- Published by Springer Nature in Cell Research
- Vol. 21 (4) , 609-626
Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis
The Slit family of guidance cues binds to Roundabout (Robo) receptors and modulates cell migration. We report here that ectopic expression of Slit2 and Robo1 or recombinant Slit2 treatment of Robo1-expressing colorectal epithelial carcinoma cells recruited an ubiquitin ligase Hakai for E-cadherin (E-cad) ubiquitination and lysosomal degradation, epithelial-mesenchymal transition (EMT), and tumor growth and liver metastasis, which were rescued by knockdown of Hakai. In contrast, knockdown of endogenous Robo1 or specific blockade of Slit2 binding to Robo1 prevented E-cad degradation and reversed EMT, resulting in diminished tumor growth and liver metastasis. Ectopic expression of Robo1 also triggered a malignant transformation in Slit2-positive human embryonic kidney 293 cells. Importantly, the expression of Slit2 and Robo1 was significantly associated with an increased metastatic risk and poorer overall survival in colorectal carcinoma patients. We conclude that engagement of Robo1 by Slit2 induces malignant transformation through Hakai-mediated E-cad ubiquitination and lysosomal degradation during colorectal epithelial cell carcinogenesis.
- 1 May 2010
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 396 (2) , 571-577
Slit–Robo signaling mediates lymphangiogenesis and promotes tumor lymphatic metastasis
- 1 May 2010
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 396 (2) , 571-577
Slit–Robo signaling mediates lymphangiogenesis and promotes tumor lymphatic metastasis
- 29 December 2009
- Published by China Science Publishing & Media Ltd. in PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS
- Vol. 36 (5) , 601-607
Generation and Application of Active Recombinant Mouse Tissue Factor and Its Function-blocking Monoclonal Antibody*
- 29 December 2009
- Published by China Science Publishing & Media Ltd. in PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS
- Vol. 36 (5) , 601-607
Generation and Application of Active Recombinant Mouse Tissue Factor and Its Function-blocking Monoclonal Antibody*
- Open Access
- 1 February 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (7) , 4473-4483
NF-κB Transcription Factor p50 Critically Regulates Tissue Factor in Deep Vein Thrombosis
- 1 February 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (7) , 4473-4483
Open AccessNF-κB Transcription Factor p50 Critically Regulates Tissue Factor in Deep Vein Thrombosis
- 16 October 2007
- Published by Springer Nature in Cell Research
- Vol. 17 (11) , 933-941
Andrographolide inhibits NF-κB activation and attenuates neointimal hyperplasia in arterial restenosis
The NF-κB transcription factors modulate the expression of tissue factor (TF), E-selectin (CD62E) and vascular cell adhesion molecule-1 (VCAM-1), which are essential for thrombosis and inflammation. We have previously shown that andrographolide (Andro) covalently modifies the reduced cysteine62 of p50 – a major subunit of NF-κB transcription factors, thus blocking the binding of NF-κB transcription factors to the promoters of their target genes, preventing NF-κB activation and inhibiting inflammation in vitro and in vivo. Here we report that Andro, but not its inactive structural analog 4H-Andro, significantly suppressed the proliferation of arterial neointima (~60% reduction) in a murine model of arterial restenosis. Consistently, p50−/− mice manifested attenuated neointimal hyperplasia upon arterial ligation. Notably, the same dosage of Andro did not further reduce neointimal formation in p50−/− mice, which implicates the specificity of Andro on p50 for treating experimental arterial restenosis. The upregulation of NF-κB target genes, including TF, E-selectin and VCAM-1, and the increased deposition of leukocytes (mainly CD68+ macrophages) were clearly detected within the injured arterial walls, all of which were significantly abolished by treatment with Andro or genetic deletion of p50. The expression of TF, E-selectin and VCAM-1 was also markedly upregulated in the patient sample of thrombotic vasculitis, indicating the clinical relevance of NF-κB activation in the pathogeneses of occlusive arterial diseases. Our data thus indicate that, by the downregulation of the NF-κB target genes that are critical in thrombosis and inflammation, specific inhibitors of p50, such as Andro, may be therapeutically valuable for preventing and treating thrombotic arterial diseases, including neointimal hyperplasia in arterial restenosis.
- 16 October 2007
- Published by Springer Nature in Cell Research
- Vol. 17 (11) , 933-941
Andrographolide inhibits NF-κB activation and attenuates neointimal hyperplasia in arterial restenosis
The NF-κB transcription factors modulate the expression of tissue factor (TF), E-selectin (CD62E) and vascular cell adhesion molecule-1 (VCAM-1), which are essential for thrombosis and inflammation. We have previously shown that andrographolide (Andro) covalently modifies the reduced cysteine62 of p50 – a major subunit of NF-κB transcription factors, thus blocking the binding of NF-κB transcription factors to the promoters of their target genes, preventing NF-κB activation and inhibiting inflammation in vitro and in vivo. Here we report that Andro, but not its inactive structural analog 4H-Andro, significantly suppressed the proliferation of arterial neointima (~60% reduction) in a murine model of arterial restenosis. Consistently, p50−/− mice manifested attenuated neointimal hyperplasia upon arterial ligation. Notably, the same dosage of Andro did not further reduce neointimal formation in p50−/− mice, which implicates the specificity of Andro on p50 for treating experimental arterial restenosis. The upregulation of NF-κB target genes, including TF, E-selectin and VCAM-1, and the increased deposition of leukocytes (mainly CD68+ macrophages) were clearly detected within the injured arterial walls, all of which were significantly abolished by treatment with Andro or genetic deletion of p50. The expression of TF, E-selectin and VCAM-1 was also markedly upregulated in the patient sample of thrombotic vasculitis, indicating the clinical relevance of NF-κB activation in the pathogeneses of occlusive arterial diseases. Our data thus indicate that, by the downregulation of the NF-κB target genes that are critical in thrombosis and inflammation, specific inhibitors of p50, such as Andro, may be therapeutically valuable for preventing and treating thrombotic arterial diseases, including neointimal hyperplasia in arterial restenosis.
- Open Access
- 1 July 2007
- Published by Taylor & Francis in Cell Adhesion & Migration
- Vol. 1 (3) , 115-123
P-selectin Cross-links PSGL-1 and Enhances Neutrophil Adhesion to Fibrinogen and ICAM-1 in a Src Kinase-Dependent, but GPCR-Independent Mechanism
Endothelial and platelet P-selectin (CD62P) and leukocyte integrin αMβ2 (CD11bCD18, Mac-1) are cell adhesion molecules essential for host defense and innate immunity. Upon inflammatory challenges, ...
- 1 July 2007
- Published by Taylor & Francis in Cell Adhesion & Migration
- Vol. 1 (3) , 115-123
Open AccessP-selectin Cross-links PSGL-1 and Enhances Neutrophil Adhesion to Fibrinogen and ICAM-1 in a Src Kinase-Dependent, but GPCR-Independent Mechanism
Endothelial and platelet P-selectin (CD62P) and leukocyte integrin αMβ2 (CD11bCD18, Mac-1) are cell adhesion molecules essential for host defense and innate immunity. Upon inflammatory challenges, ...